The acute ischemic stroke diagnosis market size has grown strongly in recent years. It will grow from $2.48 billion in 2025 to $2.65 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to limited accessibility to advanced imaging technologies, reliance on conventional stroke diagnosis methods, increasing stroke prevalence worldwide, growing awareness of early stroke intervention, expansion of hospital neurology departments.
The acute ischemic stroke diagnosis market size is expected to see strong growth in the next few years. It will grow to $3.5 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to development of ai-driven diagnostic tools, rising investment in telehealth infrastructure, growth in point-of-care stroke diagnostics, increasing adoption of minimally invasive procedures, expansion of stroke centers and specialized neurology units. Major trends in the forecast period include increasing adoption of advanced imaging modalities for ais diagnosis, rising use of non-invasive diagnostic techniques, growing implementation of telemedicine and remote monitoring, expansion of rapid diagnostic protocols in hospitals, integration of AI-based predictive analytics for stroke detection.
The rising prevalence of acute ischemic stroke cases is expected to drive the growth of the acute ischemic stroke diagnosis market going forward. Acute ischemic stroke is a serious medical emergency caused by reduced blood flow to the brain, leading to the destruction of brain cells. Early diagnosis of acute ischemic stroke supports timely treatment and helps minimize brain damage and other complications associated with the condition. For instance, in April 2024, according to a report published by the Stroke Association, a UK-based charity, the projected cost of stroke in the UK is expected to increase from £43 billion next year to £75 billion by 2035, reflecting nearly a 200% rise over 20 years. Additionally, 1 in 4 strokes affects working-age individuals, resulting in an annual productivity loss of £1.6 billion, which is projected to grow by 136% by 2035. Therefore, the rising prevalence of acute ischemic stroke cases is fueling growth in the acute ischemic stroke diagnosis market.
Major companies operating in the acute ischemic stroke diagnosis market are focusing on strategic partnerships to gain a competitive advantage. These collaborations aim to enhance the development and accessibility of advanced diagnostic tools, such as computed tomography (CT), magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, and echocardiography, all of which are essential for accurate and timely stroke diagnosis. For instance, in October 2023, Brainomix Ltd., a US-based AI-powered MedTech solutions company, partnered with Nanoflex Robotics AG, a Switzerland-based developer of soft robotic systems, to develop an AI robotics platform for acute ischemic stroke treatment. This system is an AI-assisted magnetic navigation tool for stroke-related robotic surgical devices. The collaboration integrates the companies’ technologies to provide an AI-assisted navigation solution that guides catheters and other devices through the vascular system. The project aims to enhance Nanoflex Robotics' magnetic robotic navigation system with AI, making it the first platform capable of enabling remote thrombectomy and transforming stroke therapy while improving patient outcomes.
In February 2025, Brainomix, a UK-based digital health company providing diagnostic support for acute ischemic stroke, announced a strategic partnership with Medtronic Neurovascular to improve diagnostic accuracy and patient outcomes. Through this partnership, Brainomix seeks to advance acute ischemic stroke diagnosis in Western Europe by integrating its AI-powered stroke imaging software with Medtronic’s clinical expertise and devices, enhancing diagnosis, treatment accessibility, and patient outcomes across the stroke care continuum. Medtronic Neurovascular is a US-based medical technology company specializing in neurovascular interventions.
Major companies operating in the acute ischemic stroke diagnosis market are Siemens Healthineers AG, GE HealthCare Technologies Inc., Philips Healthcare, Canon Medical Systems Corporation, FUJIFILM Medical Systems, Samsung Neurologica Corporation, Nihon Kohden Corporation, Neusoft Medical Systems Co. Ltd., Hyperfine Research Inc., Olea Medical, iSchemaView Inc., NovaSignal Corporation, RapidAI Inc., Viz.ai Inc., Brainomix Ltd., Nicolet Neuro Inc., Compumedics Limited, Electrical Geodesics Inc., Mediso Medical Imaging Systems, Esaote SpA, United Imaging Healthcare, Shimadzu Corporation.
North America was the largest region in the acute ischemic stroke diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute ischemic stroke diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the acute ischemic stroke diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have impacted the acute ischemic stroke diagnosis market by increasing costs for imported imaging equipment, AI-based diagnostic software, and specialized monitoring devices. Diagnostic segments like MRI, CT, and cerebral angiography are most affected, with regions such as north america, europe, and asia-pacific experiencing higher procurement costs. While tariffs may slow adoption due to increased equipment prices, they also incentivize local manufacturing, promote domestic innovation, and encourage development of cost-effective diagnostic solutions.
The acute ischemic stroke diagnosis market research report is one of a series of new reports that provides acute ischemic stroke diagnosis market statistics, including acute ischemic stroke diagnosis industry global market size, regional shares, competitors with a acute ischemic stroke diagnosis market share, detailed acute ischemic stroke diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the acute ischemic stroke diagnosis industry. This acute ischemic stroke diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An acute ischemic stroke (AIS) diagnosis refers to the identification of a condition characterized by a sudden loss of blood flow to a part of the brain, resulting in a loss of neurological function. AIS diagnosis helps detect and determine the sources of the clot responsible for the abrupt reduction in blood flow.
The main types of acute ischemic stroke diagnosis include computed tomography (CT), magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography (ECG), echocardiography, and others. A CT scan is a procedure that produces a series of detailed images of different body parts using a computer connected to an X-ray machine. Surgical interventions associated with AIS include carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomy. These procedures are applied in treatments involving tissue plasminogen activator (TPA), anticoagulants, antiplatelets, and antihypertensives.
The acute ischemic stroke (AIS) diagnosis market includes revenues earned by entities through physical exams, thrombolysis, blood tests, and other imaging techniques. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The acute ischemic stroke diagnosis market size is expected to see strong growth in the next few years. It will grow to $3.5 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to development of ai-driven diagnostic tools, rising investment in telehealth infrastructure, growth in point-of-care stroke diagnostics, increasing adoption of minimally invasive procedures, expansion of stroke centers and specialized neurology units. Major trends in the forecast period include increasing adoption of advanced imaging modalities for ais diagnosis, rising use of non-invasive diagnostic techniques, growing implementation of telemedicine and remote monitoring, expansion of rapid diagnostic protocols in hospitals, integration of AI-based predictive analytics for stroke detection.
The rising prevalence of acute ischemic stroke cases is expected to drive the growth of the acute ischemic stroke diagnosis market going forward. Acute ischemic stroke is a serious medical emergency caused by reduced blood flow to the brain, leading to the destruction of brain cells. Early diagnosis of acute ischemic stroke supports timely treatment and helps minimize brain damage and other complications associated with the condition. For instance, in April 2024, according to a report published by the Stroke Association, a UK-based charity, the projected cost of stroke in the UK is expected to increase from £43 billion next year to £75 billion by 2035, reflecting nearly a 200% rise over 20 years. Additionally, 1 in 4 strokes affects working-age individuals, resulting in an annual productivity loss of £1.6 billion, which is projected to grow by 136% by 2035. Therefore, the rising prevalence of acute ischemic stroke cases is fueling growth in the acute ischemic stroke diagnosis market.
Major companies operating in the acute ischemic stroke diagnosis market are focusing on strategic partnerships to gain a competitive advantage. These collaborations aim to enhance the development and accessibility of advanced diagnostic tools, such as computed tomography (CT), magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, and echocardiography, all of which are essential for accurate and timely stroke diagnosis. For instance, in October 2023, Brainomix Ltd., a US-based AI-powered MedTech solutions company, partnered with Nanoflex Robotics AG, a Switzerland-based developer of soft robotic systems, to develop an AI robotics platform for acute ischemic stroke treatment. This system is an AI-assisted magnetic navigation tool for stroke-related robotic surgical devices. The collaboration integrates the companies’ technologies to provide an AI-assisted navigation solution that guides catheters and other devices through the vascular system. The project aims to enhance Nanoflex Robotics' magnetic robotic navigation system with AI, making it the first platform capable of enabling remote thrombectomy and transforming stroke therapy while improving patient outcomes.
In February 2025, Brainomix, a UK-based digital health company providing diagnostic support for acute ischemic stroke, announced a strategic partnership with Medtronic Neurovascular to improve diagnostic accuracy and patient outcomes. Through this partnership, Brainomix seeks to advance acute ischemic stroke diagnosis in Western Europe by integrating its AI-powered stroke imaging software with Medtronic’s clinical expertise and devices, enhancing diagnosis, treatment accessibility, and patient outcomes across the stroke care continuum. Medtronic Neurovascular is a US-based medical technology company specializing in neurovascular interventions.
Major companies operating in the acute ischemic stroke diagnosis market are Siemens Healthineers AG, GE HealthCare Technologies Inc., Philips Healthcare, Canon Medical Systems Corporation, FUJIFILM Medical Systems, Samsung Neurologica Corporation, Nihon Kohden Corporation, Neusoft Medical Systems Co. Ltd., Hyperfine Research Inc., Olea Medical, iSchemaView Inc., NovaSignal Corporation, RapidAI Inc., Viz.ai Inc., Brainomix Ltd., Nicolet Neuro Inc., Compumedics Limited, Electrical Geodesics Inc., Mediso Medical Imaging Systems, Esaote SpA, United Imaging Healthcare, Shimadzu Corporation.
North America was the largest region in the acute ischemic stroke diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute ischemic stroke diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the acute ischemic stroke diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have impacted the acute ischemic stroke diagnosis market by increasing costs for imported imaging equipment, AI-based diagnostic software, and specialized monitoring devices. Diagnostic segments like MRI, CT, and cerebral angiography are most affected, with regions such as north america, europe, and asia-pacific experiencing higher procurement costs. While tariffs may slow adoption due to increased equipment prices, they also incentivize local manufacturing, promote domestic innovation, and encourage development of cost-effective diagnostic solutions.
The acute ischemic stroke diagnosis market research report is one of a series of new reports that provides acute ischemic stroke diagnosis market statistics, including acute ischemic stroke diagnosis industry global market size, regional shares, competitors with a acute ischemic stroke diagnosis market share, detailed acute ischemic stroke diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the acute ischemic stroke diagnosis industry. This acute ischemic stroke diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An acute ischemic stroke (AIS) diagnosis refers to the identification of a condition characterized by a sudden loss of blood flow to a part of the brain, resulting in a loss of neurological function. AIS diagnosis helps detect and determine the sources of the clot responsible for the abrupt reduction in blood flow.
The main types of acute ischemic stroke diagnosis include computed tomography (CT), magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography (ECG), echocardiography, and others. A CT scan is a procedure that produces a series of detailed images of different body parts using a computer connected to an X-ray machine. Surgical interventions associated with AIS include carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomy. These procedures are applied in treatments involving tissue plasminogen activator (TPA), anticoagulants, antiplatelets, and antihypertensives.
The acute ischemic stroke (AIS) diagnosis market includes revenues earned by entities through physical exams, thrombolysis, blood tests, and other imaging techniques. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Acute Ischemic Stroke Diagnosis Market Characteristics
3. Acute Ischemic Stroke Diagnosis Market Supply Chain Analysis
4. Global Acute Ischemic Stroke Diagnosis Market Trends and Strategies
5. Acute Ischemic Stroke Diagnosis Market Analysis of End Use Industries
7. Global Acute Ischemic Stroke Diagnosis Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Acute Ischemic Stroke Diagnosis Total Addressable Market (TAM) Analysis for the Market
9. Acute Ischemic Stroke Diagnosis Market Segmentation
10. Acute Ischemic Stroke Diagnosis Market Regional and Country Analysis
11. Asia-Pacific Acute Ischemic Stroke Diagnosis Market
12. China Acute Ischemic Stroke Diagnosis Market
13. India Acute Ischemic Stroke Diagnosis Market
14. Japan Acute Ischemic Stroke Diagnosis Market
15. Australia Acute Ischemic Stroke Diagnosis Market
16. Indonesia Acute Ischemic Stroke Diagnosis Market
17. South Korea Acute Ischemic Stroke Diagnosis Market
18. Taiwan Acute Ischemic Stroke Diagnosis Market
19. South East Asia Acute Ischemic Stroke Diagnosis Market
20. Western Europe Acute Ischemic Stroke Diagnosis Market
21. UK Acute Ischemic Stroke Diagnosis Market
22. Germany Acute Ischemic Stroke Diagnosis Market
23. France Acute Ischemic Stroke Diagnosis Market
24. Italy Acute Ischemic Stroke Diagnosis Market
25. Spain Acute Ischemic Stroke Diagnosis Market
26. Eastern Europe Acute Ischemic Stroke Diagnosis Market
27. Russia Acute Ischemic Stroke Diagnosis Market
28. North America Acute Ischemic Stroke Diagnosis Market
29. USA Acute Ischemic Stroke Diagnosis Market
30. Canada Acute Ischemic Stroke Diagnosis Market
31. South America Acute Ischemic Stroke Diagnosis Market
32. Brazil Acute Ischemic Stroke Diagnosis Market
33. Middle East Acute Ischemic Stroke Diagnosis Market
34. Africa Acute Ischemic Stroke Diagnosis Market
36. Acute Ischemic Stroke Diagnosis Market Competitive Landscape and Company Profiles
37. Acute Ischemic Stroke Diagnosis Market Other Major and Innovative Companies
40. Acute Ischemic Stroke Diagnosis Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Acute Ischemic Stroke Diagnosis Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses acute ischemic stroke diagnosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for acute ischemic stroke diagnosis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The acute ischemic stroke diagnosis market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Diagnostic Type: Computed Tomography (CT); Magnetic Resonance Imaging (MRI); Carotid Ultrasound; Cerebral Angiography; Electrocardiography (ECG); Echocardiography; Other Diagnostic Types2) By Imaging Type: Structural Imaging; Vascular Imaging; Perfusion Imaging
3) By End User: Hospitals; Specialty Neurology Clinics; Diagnostic Imaging Centers; Academic and Research Institutes
Subsegments:
1) By Computed Tomography (CT): Non-Contrast CT; CT Angiography2) By Magnetic Resonance Imaging (MRI): MRI With Diffusion-Weighted Imaging (DWI); MRI Angiography
3) By Carotid Ultrasound: Doppler Ultrasound; B-Mode Ultrasound
4) By Cerebral Angiography: Digital Subtraction Angiography (DSA); Catheter Angiography
5) By Electrocardiography (ECG): Standard ECG; Holter Monitoring
6) By Echocardiography: Transthoracic Echocardiography (TTE); Transesophageal Echocardiography (TEE)
7) By Other Diagnostics: Blood Tests; Neurological Examination; CT Perfusion
Companies Mentioned: Siemens Healthineers AG; GE HealthCare Technologies Inc.; Philips Healthcare; Canon Medical Systems Corporation; FUJIFILM Medical Systems; Samsung Neurologica Corporation; Nihon Kohden Corporation; Neusoft Medical Systems Co. Ltd.; Hyperfine Research Inc.; Olea Medical; iSchemaView Inc.; NovaSignal Corporation; RapidAI Inc.; Viz.ai Inc.; Brainomix Ltd.; Nicolet Neuro Inc.; Compumedics Limited; Electrical Geodesics Inc.; Mediso Medical Imaging Systems; Esaote SpA; United Imaging Healthcare; Shimadzu Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Acute Ischemic Stroke Diagnosis market report include:- Siemens Healthineers AG
- GE HealthCare Technologies Inc.
- Philips Healthcare
- Canon Medical Systems Corporation
- FUJIFILM Medical Systems
- Samsung Neurologica Corporation
- Nihon Kohden Corporation
- Neusoft Medical Systems Co. Ltd.
- Hyperfine Research Inc.
- Olea Medical
- iSchemaView Inc.
- NovaSignal Corporation
- RapidAI Inc.
- Viz.ai Inc.
- Brainomix Ltd.
- Nicolet Neuro Inc.
- Compumedics Limited
- Electrical Geodesics Inc.
- Mediso Medical Imaging Systems
- Esaote SpA
- United Imaging Healthcare
- Shimadzu Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.65 Billion |
| Forecasted Market Value ( USD | $ 3.5 Billion |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
